Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143492 |
| CAS No | NA |
| Mol.F. | C14H16N6O2 |
| Mol.Wt. | 300.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143493 |
| CAS No | NA |
| Mol.F. | C8H11N3O3S |
| Mol.Wt. | 229.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143494 |
| CAS No | 53743-85-4 |
| Mol.F. | C10H14N2O · HCl |
| Mol.Wt. | 214.69 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143496 |
| CAS No | NA |
| Mol.F. | C19H24N6O3 |
| Mol.Wt. | 384.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143497 |
| CAS No | NA |
| Mol.F. | C21H29N7O2S |
| Mol.Wt. | 443.57 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143498 |
| CAS No | NA |
| Mol.F. | C16H25N5O4S |
| Mol.Wt. | 383.47 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143499 |
| CAS No | 120-22-9 |
| Mol.F. | C10H14N2O |
| Mol.Wt. | 178.24 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143500 |
| CAS No | NA |
| Mol.F. | C8H9N3O5 |
| Mol.Wt. | 227.18 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143501 |
| CAS No | NA |
| Mol.F. | C22H18N4O5 |
| Mol.Wt. | 418.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143502 |
| CAS No | NA |
| Mol.F. | C22H18N4O5 |
| Mol.Wt. | 418.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143503 |
| CAS No | NA |
| Mol.F. | C22H18N4O7 |
| Mol.Wt. | 450.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143504 |
| CAS No | NA |
| Mol.F. | C22H18N4O7 |
| Mol.Wt. | 450.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143505 |
| CAS No | NA |
| Mol.F. | C22H18N4O7 |
| Mol.Wt. | 450.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143506 |
| CAS No | NA |
| Mol.F. | C22H18N4O6 |
| Mol.Wt. | 434.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143507 |
| CAS No | NA |
| Mol.F. | C21H18ClN5O5 |
| Mol.Wt. | 455.9 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143508 |
| CAS No | NA |
| Mol.F. | C10H10ClN3O3 |
| Mol.Wt. | 255.66 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |